150 related articles for article (PubMed ID: 23790244)
21. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoids in rheumatoid arthritis: current status and future studies.
Hua C; Buttgereit F; Combe B
RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
[TBL] [Abstract][Full Text] [Related]
23. [Use of glucocorticoids in rheumatoid arthritis].
Jacobsen S
Ugeskr Laeger; 2000 Feb; 162(6):770-2. PubMed ID: 10689949
[TBL] [Abstract][Full Text] [Related]
24. Dose-related patterns of glucocorticoid-induced side effects.
Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
Ann Rheum Dis; 2009 Jul; 68(7):1119-24. PubMed ID: 18684744
[TBL] [Abstract][Full Text] [Related]
25. Is There a Renaissance of Glucocorticoids in Rheumatoid Arthritis?
Kirwan JR; Gunasekera W
Clin Pharmacol Ther; 2017 Oct; 102(4):574-577. PubMed ID: 28783220
[TBL] [Abstract][Full Text] [Related]
26. Role of abatacept in the management of rheumatoid arthritis.
Nogid A; Pham DQ
Clin Ther; 2006 Nov; 28(11):1764-78. PubMed ID: 17212998
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
Kirwan J; Power L
Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
[TBL] [Abstract][Full Text] [Related]
29. Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
Amann J; Wessels AM; Breitenfeldt F; Huscher D; Bijlsma JWJ; Jacobs JWG; Buttgereit F
Clin Exp Rheumatol; 2017; 35(3):471-476. PubMed ID: 28094753
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid treatment in rheumatoid arthritis.
Rau R
Expert Opin Pharmacother; 2014 Aug; 15(11):1575-83. PubMed ID: 24856989
[TBL] [Abstract][Full Text] [Related]
31. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study.
Aviña-Zubieta JA; Abrahamowicz M; De Vera MA; Choi HK; Sayre EC; Rahman MM; Sylvestre MP; Wynant W; Esdaile JM; Lacaille D
Rheumatology (Oxford); 2013 Jan; 52(1):68-75. PubMed ID: 23192907
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
Park HJ; Ranganathan P
Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
[TBL] [Abstract][Full Text] [Related]
33. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
Dulai R; Perry M; Twycross-Lewis R; Morrissey D; Atzeni F; Greenwald S
Semin Arthritis Rheum; 2012 Aug; 42(1):1-8. PubMed ID: 22475245
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
[TBL] [Abstract][Full Text] [Related]
35. Analyses of similarities and differences in glucocorticoid therapy between rheumatoid arthritis and ankylosing spondylitis - a systematic comparison.
Spies CM; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S152-8. PubMed ID: 19822064
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis.
Verhoeven F; Prati C; Maguin-Gaté K; Wendling D; Demougeot C
Arthritis Res Ther; 2016 Nov; 18(1):258. PubMed ID: 27814748
[TBL] [Abstract][Full Text] [Related]
37. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint.
Cutolo M; Kitas GD; van Riel PL
Semin Arthritis Rheum; 2014 Feb; 43(4):479-88. PubMed ID: 24080116
[TBL] [Abstract][Full Text] [Related]
38. The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Black RJ; Hill CL; Lester S; Dixon WG
PLoS One; 2016; 11(11):e0166468. PubMed ID: 27846316
[TBL] [Abstract][Full Text] [Related]
39. Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.
Kavanaugh A; Wells AF
Rheumatology (Oxford); 2014 Oct; 53(10):1742-51. PubMed ID: 24729402
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids in rheumatoid arthritis.
Caporali R; Todoerti M; Sakellariou G; Montecucco C
Drugs; 2013 Jan; 73(1):31-43. PubMed ID: 23335134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
